NF-κB functions as a tumour promoter in inflammation-associated cancer

Nature

Volumn 431, Issue 7007, 2004, Pages 461-466

  Pikarsky, Eli ^a   Porat, Rinnat M ^a   Stein, Ilan ^a,b   Abramovitch, Rinat ^c   Amit, Sharon ^b   Kasem, Shafika ^a   Gutkovich Pyest, Elena ^b   Uriell Shoval, Simcha ^a   Galun, Eithan ^c   Ben Neriah, Yinon ^b  

^a HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^b HEBREW UNIVERSITY   (Israel)

^c HEBREW UNIVERSITY OF JERUSALEM   (Israel)

Author keywords

[No Author keywords available]

Indexed keywords

APPROXIMATION THEORY; CARCINOGENS; CELLS; DISEASE CONTROL; GENES;

CARCINOMA; CHRONIC INFLAMMATION; INFLAMMATORY DISEASE;

TUMORS;

I KAPPA B; IBUPROFEN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; TUMOR NECROSIS FACTOR ALPHA; ABC TRANSPORTER; GLYCOPROTEIN P; MULTIDRUG RESISTANCE PROTEIN 3;

CANCER; MEDICINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; APOPTOSIS; ARTICLE; CANCER GROWTH; CANCER STAGING; CELL TRANSFORMATION; CHOLESTATIC HEPATITIS; CONTROLLED STUDY; DISEASE ASSOCIATION; ENDOTHELIUM CELL; INFLAMMATORY CELL; KNOCKOUT MOUSE; LIVER CELL CARCINOMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; UPREGULATION; ANIMAL; CHRONIC DISEASE; DISEASE COURSE; GENETICS; HEPATITIS; INFLAMMATION; LIVER; LIVER CELL; METABOLISM; MOUSE MUTANT; PARACRINE SIGNALING; PATHOLOGY;

ANIMALIA;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; CARCINOMA, HEPATOCELLULAR; CHRONIC DISEASE; DISEASE PROGRESSION; HEPATITIS; HEPATOCYTES; I-KAPPA B PROTEINS; INFLAMMATION; LIVER; MICE; MICE, KNOCKOUT; NF-KAPPA B; P-GLYCOPROTEINS; PARACRINE COMMUNICATION; TUMOR NECROSIS FACTOR-ALPHA;

EID: 4644324186     PISSN: 00280836     EISSN: None     Source Type: Journal    
DOI: 10.1038/nature02924     Document Type: Article

References (27)

1. Coussens, L. M. & Werb, Z. Inflammation and cancer. Nature 420, 860-867 (2002).
2. Balmain, A. & Harris, C. C. Carcinogenesis in mouse and human cells: parallels and paradoxes. Carcinogenesis 21, 371-377 (2000).
3. Li, Q. & Verma, I. M. NF-κB regulation in the immune system. Nature Rev. Immunol. 2, 725-734 (2002).
4. Mayo, M. W. & Baldwin, A. S. The transcription factor NF-κB: control of oncogenesis and cancer therapy resistance. Biochim. Biophys. Acta 1470, M55-M62 (2000).
5. Lin, A. & Karin, M. NF-κB in cancer: a marked target. Semin. Cancer Biol. 13, 107-114 (2003).
6. Mauad, T. H. et al. Mice with homozygous disruption of the mdr2 P-glycoprotein gene. A novel animal model for studies of nonsuppurative inflammatory cholangitis and hepatocarcinogenesis. Am. J. Pathol. 145, 1237-1245 (1994).
7. Nakamoto, Y., Guidotti, L. G., Kuhlen, C. V., Fowler, P. & Chisari, F. V. Immune pathogenesis of hepatocellular carcinoma. J. Exp. Med. 188, 341-350 (1998).
8. Block, T. M., Mehta, A. S., Fimmel, C. J. & Jordan, R. Molecular viral oncology of hepatocellular carcinoma. Oncogene 22, 5093-5107 (2003).
9. De Vree, J. M. et al. Correction of liver disease by hepatocyte transplantation in a mouse model of progressive familial intrahepatic cholestasis. Gastroenterology 119, 1720-1730 (2000).
10. Staudt, L. M. Molecular diagnosis of the hematologic cancers. N. Engl. J. Med. 348, 1777-1785 (2003).
11. Lavon, I. et al. High susceptibility to bacterial infection, but no liver dysfunction, in mice compromised for hepatocyte NF-κB activation. Nature Med. 6, 573-577 (2000).
12. Gupta, S. Hepatic polyploidy and liver growth control. Semin. Cancer Biol. 10, 161-171 (2000).
13. Bruix, J., Boix, L., Sala, M. & Llovet, J. M. Focus on hepatocellular carcinoma. Cancer Cell 5, 215-219 (2004).
14. Chaisson, M. L., Brooling, J. T., Ladiges, W., Tsai, S. & Fausto, N. Hepatocyte-specific inhibition of NF-κB leads to apoptosis after TNF treatment, but not after partial hepatectomy. J. Clin. Invest. 110, 193-202 (2002).
15. Maeda, S. et al. IKKβ is required for prevention of apoptosis mediated by cell-bound but not by circulating TNFα. Immunity 19, 725-737 (2003).
16. Beg, A. A., Sha, W. C., Bronson, R. T., Ghosh, S. & Baltimore, D. Embryonic lethality and liver degeneration in mice lacking the RelA component of NF-κB. Nature 376, 167-170 (1995).
17. Lavon, I. et al. Nuclear factor-κB protects the liver against genotoxic stress and functions independently of p53. Cancer Res. 63, 25-30 (2003).
18. Friedberg, E. C., McDaniel, L. D. & Schultz, R. A. The role of endogenous and exogenous DNA damage and mutagenesis. Curr. Opin. Genet. Dev. 14, 5-10 (2004).
19. Wang, J. S. & Groopman, J. D. DNA damage by mycotoxins. Mutat. Res. 424, 167-181 (1999).
20. Eferl, R. et al. Liver tumor development. c-Jun antagonizes the proapoptotic activity of p53. Cell 112, 181-192 (2003).
21. Ehrhardt, H. et al. TRAIL induced survival and proliferation in cancer cells resistant towards TRAIL-induced apoptosis mediated by NF-κB. Oncogene 22, 3842-3852 (2003).
22. Kennedy, N. J. & Davis, R. J. Role of JNK in tumor development. Cell Cycle 2, 199-201 (2003).
23. Tang, G. et al. Inhibition of JNK activation through NF-κB target genes. Nature 414, 313-317 (2001).
24. Papa, S. et al. Gadd45 β mediates the NF-κB suppression of JNK signalling by targeting MKK7/JNKK2. Nature Cell Biol. 6, 146-153 (2004).
25. Greten, F. R. et al. Ikkβ links inflammation and tumorigenesis in a mouse model of colitis-associated cancer. Cell 118, 285-296 (2004).
26. Wilson, J. & Balkwill, F. The role of cytokines in the epithelial cancer microenvironment. Semin. Cancer Biol. 12, 113-120 (2002).
27. Radisky, D., Hagios, C. & Bissell, M.J. Tumors are unique organs defined by abnormal signaling and context. Semin. Cancer Biol. 11, 87-95 (2001).